S. V. Sharma, D. Y. Lee, B. Li, M. P. Quinlan, F. Takahashi et al., A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations, Cell, vol.141, issue.1, p.69, 2010.
DOI : 10.1016/j.cell.2010.02.027

C. A. Aktipis, A. M. Boddy, R. A. Gatenby, J. S. Brown, and C. C. Maley, Life history trade-offs in cancer evolution, Nature Reviews Cancer, vol.269, issue.12, p.883, 2013.
DOI : 10.1038/nrc3606

A. Kreso, C. A. O-'brien, P. Van-galen, O. I. Gan, F. Notta et al., Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer, Science, vol.339, issue.6119, p.543, 2013.
DOI : 10.1126/science.1227670

K. P. Williams, J. L. Allensworth, S. M. Ingram, G. R. Smith, A. J. Aldrich et al., Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization, Cancer Letters, vol.337, issue.1, p.77, 2013.
DOI : 10.1016/j.canlet.2013.05.017

A. R. Anderson, A. M. Weaver, P. T. Cummings, and V. Quaranta, Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment, Cell, vol.127, issue.5, p.905, 2006.
DOI : 10.1016/j.cell.2006.09.042

D. A. Charlebois, N. Abdennur, and M. Kaern, Gene Expression Noise Facilitates Adaptation and Drug Resistance Independently of Mutation, Physical Review Letters, vol.107, issue.21, p.218101, 2011.
DOI : 10.1103/PhysRevLett.107.218101

A. S. Silva and R. A. Gatenby, A theoretical quantitative model for evolution of cancer chemotherapy resistance, Biology Direct, vol.5, issue.1, p.25, 2010.
DOI : 10.1186/1745-6150-5-25

O. Lavi, J. M. Greene, D. Levy, and M. M. Gottesman, The Role of Cell Density and Intratumoral Heterogeneity in Multidrug Resistance, Cancer Research, vol.73, issue.24, p.7168, 2013.
DOI : 10.1158/0008-5472.CAN-13-1768

A. Lorz, T. Lorenzi, and M. E. Hochberg, Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies, ESAIM: Mathematical Modelling and Numerical Analysis, vol.47, issue.2, p.377, 2013.
DOI : 10.1051/m2an/2012031

URL : https://hal.archives-ouvertes.fr/hal-00714274

R. J. Gillies, I. Robey, and R. A. Gatenby, Causes and Consequences of Increased Glucose Metabolism of Cancers, Journal of Nuclear Medicine, vol.49, issue.Suppl_2, p.24, 2008.
DOI : 10.2967/jnumed.107.047258

K. S. Korolev, J. B. Xavier, and J. Gore, Turning ecology and evolution against cancer, Nature Reviews Cancer, vol.148, issue.5, p.371, 2014.
DOI : 10.1038/nature13187

C. Becker, J. Hagmann, J. Müller, D. Koenig, O. Stegle et al., Spontaneous epigenetic variation in the Arabidopsis thaliana methylome, Nature, vol.29, issue.7376, p.245, 2011.
DOI : 10.1038/nature10555

T. Clozel, S. Yang, R. L. Elstrom, W. Tam, P. Martin et al., Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma, Cancer Discovery, vol.3, issue.9, p.1002, 2013.
DOI : 10.1158/2159-8290.CD-13-0117

R. A. Juergens, J. Wrangle, F. P. Vendetti, S. C. Murphy, M. Zhao et al., Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer, Cancer Discovery, vol.1, issue.7, p.598, 2011.
DOI : 10.1158/2159-8290.CD-11-0214

W. Timp and A. P. Feinberg, Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host, Nature Reviews Cancer, vol.101, issue.7, p.497, 2013.
DOI : 10.1038/nrc3486